4.3.3.2	2,4-dinitrofluorobenzene	5 mM, no inactivation after 30 min and 15% inactivation after 120 min in Tris-HCl, pH 8.0	7981	
4.3.3.2	3-alpha(S)-strictosidine	-	12852	
4.3.3.2	3-[(tert-butoxycarbonyl)amino]propyl (3R,4S)-3-ethenyl-2-(beta-D-glucopyranosyloxy)-4-(2-oxoethyl)-3,4-dihydro-2H-pyran-5-carboxylate	-	63596	
4.3.3.2	4-(2-aminoethyl)-benzenesulfonyl fluoride	4 mM, 4% inactivation after 30 min and 12% inactivation after 120 min in 100 mM potassium phosphate buffer, pH 7.0	5252	
4.3.3.2	chinconine	-	49940	
4.3.3.2	cinchonidine	-	29857	
4.3.3.2	corynantheal	-	97450	
4.3.3.2	Cu2+	-	19	
4.3.3.2	diethylpyrocarbonate	1 mM, 49% inactivation after 30 min and 63% inactivation after 120 min in 100 mM potassium phosphate, pH 6.0	2270	
4.3.3.2	Dihydroquinine	-	97452	
4.3.3.2	additional information	no inhibition with secologanin	2	
4.3.3.2	additional information	no substrate inhibition	2	
4.3.3.2	additional information	no inactivation by phenylmethanesulfonyl fluoride, L-chloro-3-(4-tosyl-amido)-4-phenyl-2-butanone and L-chloro-3-(4-tosyl-amido)-7-amino-2-heptanone after 30 and 120 min in 100 mM potassium phosphate buffer, pH 7.0	2	
4.3.3.2	N,N'-dicyclohexylcarbodiimide	0.05 mM, complete inactivation after 30 min in MES, pH 6.0	1366	
4.3.3.2	N-Acetylimidazole	10 mM, 5% inactivation after 30 min and 12% inactivation after 120 min in Tris-HCl, pH 8.0	1559	
4.3.3.2	N-ethyl-5-phenylisoxazolium-3'-sulfonate	1 mM leads to 48% inactivation after 30 min and 53% inactivation after 120 min in MES, pH 6.0, 5 mM leads to 80% inactivation after 30 min and 100% inactivation after 120 min in MES, pH 6.0	6219	
4.3.3.2	p-chlormercuribenzoate	1 mM, 34% inactivation after 30 min and 35% inactivation after 120 min in 100 mM potassium phosphate, pH 6.0	16950	
4.3.3.2	p-chloromercuribenzoate	-	43	
4.3.3.2	quinidine	-	4861	
4.3.3.2	Quinine	-	2219	
4.3.3.2	Tris	-	317	
4.3.3.2	tryptamine	inhibitory above 0.7 mM	363	
4.3.3.2	tryptamine	inhibitory above 1.2 mM	363	
4.3.3.2	tryptamine	inhibitory above 1 mM, soluble and immobilized enzyme	363